Bupropion Hydrochloride Tablet, Film Coated, Extended Release
Product Images NDC 70518-3963

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Bupropion Hydrochloride (NDC 70518-3963). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Remedy_label (Remedy Label)

Remedy_label (Remedy Label)
This text appears to be the description of a medication called buPROPion HCI Extended-Release (XL) 150 mg Tablet. It suggests that the medication is available in a quantity of 30 tablets. The text also includes information about the manufacturer (ScieGen Pharmaceuticals, Inc.), the NDC number, and the lot number. The text provides a warning not to use this medication in combination with Zyban or any other medicines that contain buPROPion HCI. The directions for use are mentioned to be found in the package insert. The suggested storage temperature is between 20-25°C (58-77°F), with excursions permitted to 15.30°C (59-86°F) according to USP guidelines. Lastly, it mentions that the medication has been repackaged by RemedyRepack Inc.*
FDA Label Image

Mm2 (Bupropion HCl 150mg 70518 3963 01)

Mm2 (Bupropion HCl 150mg 70518 3963 01)
Description: This is a medication called Bupropion HCI Extended-Release (XL) 150 mg Tablet. The package contains 60 tablets. It is a prescription-only drug and the NDC number is 70518-3963-01. The manufacturer is ScieGen Pharmaceuticals, Inc. located in Hauppauge, NY. The medication should be kept out of the reach of children. There is a warning not to use it in combination with Zyban or any other medications that contain Bupropion HCI. The directions for use can be found in the package insert. The medication should be stored at a temperature between 20-25°C (58-77°F), with excursions permitted to 15-30°C (59-86°F) according to USP standards. It has been repackaged by Remedy Repack Inc. in Indiana, PA.*
FDA Label Image

Mm3 (Bupropion HCl 150mg 70518 3963 02)

Mm3 (Bupropion HCl 150mg 70518 3963 02)
This is a description of a medication called buPROPion HCI Extended-Release (XL) 150 mg Tablet. The package contains 90 tablets. The medication is available only with a prescription. The NDC number is 70518-3963-02. The medication is manufactured by ScieGen Pharmaceuticals, Inc. in Hauppaugs, NY 11788. It is important to keep this medication out of reach of children. There is a warning not to use it in combination with Zyban or any other medication containing buPROPion HCI. Directions for use can be found in the package insert. The medication should be stored at a temperature between 20-25°C (58-77°F), with excursions permitted to 15-30°C (59-86°F). The medication has been repackaged by RemedyRepack Inc. in Indiana, PA 15701.*
FDA Label Image

Bupropion Hydrochloride Chemical Structure (Bupropion Hydrochloride Sr 1)

Bupropion Hydrochloride Chemical Structure (Bupropion Hydrochloride Sr 1)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.